Xbrane Biopharma Investor Relations Material
Latest events
Q1 2024
Xbrane Biopharma
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Xbrane Biopharma
Access all reports
Segment Data
Access more data
Revenue by
Source
Outlicensed products
Contract manufacturing
Other
Expenses by
Financials
Xbrane Biopharma is a biotechnology company that develops, manufactures and sells biosimilars worldwide. Many of the company's products are approved to treat cancer patients. Xbrane Biopharma AB (publ) was founded in 2008 and is headquartered in Solna, Sweden.
Key slides for Xbrane Biopharma
Q3 2023
Xbrane Biopharma
Q4 2023
Xbrane Biopharma
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
XBRANE
Country
🇸🇪 Sweden